Stock Price
49.50
Daily Change
-0.55 -1.10%
Monthly
6.96%
Yearly
0.08%
Q2 Forecast
48.22

Recordati reported EUR384.01M in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Almirall EUR 517.4M 32K Dec/2025
GlaxoSmithKline GBP 7.18B 1.42B Dec/2025
Hikma Pharmaceutical USD 1.34B 702M Dec/2025
Orion EUR 302.9M 64.2M Mar/2026
Sanofi EUR 9.31B 1.2B Mar/2026